Indian Pharma Outlook 2026: The Changing Dynamics of India's Pharmaceutical Market

By Pranav Kumar

The annual strategic reading of Indian pharmaceuticals - written by a practitioner, for practitioners.

Every year, one story reshapes Indian pharma more than the rest. Indian Pharma Outlook exists to find that story early, follow it through to its commercial consequences, and hand the reader something usable on a Monday morning.

This is not a market-research abstract or an analyst's outside view. Each edition is researched and written by Pranav Kumar, who has spent three decades inside Indian pharmaceutical commercial operations - from field roles at Cipla to Associate Director of CRM and Customer Experience at Dr. Reddy's Laboratories. The lens is that of a customer-experience practitioner applied to an industry more often read through molecules, margins and market share.

What each edition deliversThe defining story of the year - traced from trigger to commercial consequence, with the evidence shown rather than assertedThe Praakamya Pulse - an original industry survey of practising pharma professionals, gathered at the moment events unfold and returned to the people who gave itPolicy, decoded commercially - pricing control, tax reform, tariffs and regulation read for what they mean to a brand plan, not a compliance memoChannel and market structure - quick commerce, trade generics, PCD, Jan Aushadhi and the parts of the market that syndicated audits no longer seeApplied frameworks - including the I.N.S.I.G.H.T.S. brand-planning framework and the 8-Archetype HCP Profiling Model, validated on an over 2000 -doctor datasetAn honest scorecard - every edition grades the previous year's predictions, including the ones that were wrongThe series

Indian Pharma Outlook 2025 - the inaugural edition, co-published with Intellectus Consulting, establishing the survey-led method and the frameworks that run through the series.

Indian Pharma Outlook 2026 - The Year of the GLP-1: From Patent Cliff to Price War - the second edition. Eighteen chapters on the year a patent-protected peptide became a price-collapsed commodity in a single quarter, the plateau that followed eight weeks later, three policy shocks inside nine months, and the arrival of AI in Indian commercial operations as production infrastructure rather than an innovation-deck slide.

Who this is written for

Chief executives and business heads. Marketing and sales leadership. Pharma brand managers. Product managers (PMT). Medical affairs. Market access and commercial strategy teams. Digital and analytics partners serving the industry. Healthcare investors and analysts building a view of the Indian market. And the students and faculty who will run this industry next.

A practitioner's report earns its keep only if it is useful on a Monday morning, not merely interesting on a Sunday evening.

Published annually by Praakamya, Hyderabad (India). Designing Experiences. Transforming Businesses.

• Format: Paperback
• Language: English
• ISBN: B0HDL5XJPQ
• ISBN13: 9798191231976
• Release Date: August 2026
• Publisher: Independently published
• Length: 129 Pages
• Weight: 0.41 lbs.
• Dimensions: 9.0" x 0.3" x 6.0"